2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer
- 1 June 2014
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 133 (3), 401-404
- https://doi.org/10.1016/j.ygyno.2014.04.013
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological featuresVirchows Archiv, 2012
- Prognostic Factors for Stage I Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2010
- Metastatic lymph node number in epithelial ovarian carcinoma: Does it have any clinical significance?Gynecologic Oncology, 2008
- Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancerJournal of Gynecologic Oncology, 2008
- Ovarian cancer patients with “node-positive-only” Stage IIIC disease have a more favorable outcome than Stage IIIA/BGynecologic Oncology, 2007
- Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screeningInternational Journal of Gynecologic Cancer, 2007
- Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?Gynecologic Oncology, 2006
- Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2005
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerThe Journal of Pathology, 2001
- The Validity and Significance of Substage IIIC by Node Involvement in Epithelial Ovarian Cancer: Impact of Nodal Metastasis on Patient SurvivalGynecologic Oncology, 1999